what is the difference between gip and glp 1 dual glucose-dependent insulinotropic polypeptide (GIP) glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology Biology of Incretins: GLP-1 and

Dehydration can sometimes worsen the feeling of nausea or fatigue

Tesamorelin side effects The most commonly reported side effects are injection-site reactions: redness, mild swelling, or irritation at the injection site

The study showed patients taking semaglutide drugs had an increased risk of NAION

Tirzepatide treatment was also associated with a reduction in waist circumference, systolic blood pressure, fasting insulin and plasma lipid concentrations as cardiometabolic risk parameters

Ann Neurol (2021) 90(2):22738

Solomon SD, Ostrominski JW, Wang X et al (2024) Effect of semaglutide on cardiac structure and function in patients with obesity-related heart failure